Novozymes A/S

Novozymes A/S

NVZMF

$66.92

Updated: 23/09/2026, 07:10:54

Market Cap
$31.20B
Sector
Basic Materials
Industry
Chemicals - Specialty
Country
DK
Stock valuation chart
One-year closing share-price history for NVZMF
Company Profile

Novozymes A/S, a Danish enterprise established in 1925 and headquartered in Bagsvaerd, is a leading provider of biological solutions, specializing in the production and global distribution of industrial enzymes, microorganisms, and probiotics. Its extensive reach spans across Europe, the Middle East, Africa, North America, Asia Pacific, and Latin America. The company's diverse portfolio caters to a wide array of sectors, including the food and beverage industry with innovations for baking, beverages, dairy, starch processing, and protein applications. In household care, its products enhance laundry, dishwashing, and professional cleaning. For agriculture, Novozymes supports crop production with bioyield and biocontrol technologies, alongside animal health and nutrition solutions. It also contributes to industrial processing, providing solutions for grain and technical processes, as well as bioenergy applications encompassing liquefaction, saccharification, fermentation, and the conversion of fiber and biomass. Other significant areas of focus include textile treatments (such as biopreparation, biopolishing, and denim finishing), pulp and paper production (enhancing fiber modification, bleach boosting, and deinking), and leather processing (from soaking and bating to unhairing and degreasing). Furthermore, its expertise extends to water and waste management with bioaugmentation, biogas, and sludge control technologies. Additionally, Novozymes plays a role in pharmaceuticals, offering lipases and proteases for biocatalysis and rTrypsin for cell culture, in addition to broader human health and protein-related solutions.

USD
OTC
CEO: Ester Baiget
Employees: 11,641
https://www.novonesis.com
Asset Summaries
Latest generated summaries for NVZMF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for NVZMF.
Share price
$66.92
Market cap
$31.20B
Exchange
OTC
Currency
USD
CEO
Ester Baiget
Employees
11,641
IPO date
15/10/2010
Beta
0.623
Last dividend
$0.00
Day range
$65.00 – $66.92
52-week range
$52.10 – $72.98
1-day performance
2.81%
1-year performance
28.45%
Current drawdown (1Y)
-8.30%
CIK
0001131345
CUSIP
N/A
ISIN
DK0060336014
Created
07/12/2025, 05:32:31
Last update
23/09/2026, 07:10:54

Track Novozymes A/S with an AI analyst

See which prediction-market events move NVZMF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to NVZMF from your Railway `news_articles` table.

No news found for this symbol.